BACKGROUND. In order to assess the efficacy of phytotherapeutic agents for the treatment of benign prostatic hyperplasia (BPH), a review of recently published double-blind placebo-controlled trials was undertaken. METHODS. Only those studies reviewed by the Other Medical Therapies Committee of the Fourth International Consultation on BPH were included. RESULTS. These studies suggest a possible benefit for the use of phytotherapeutic preparations in the treatment of BPH. CONCLUSIONS. These studies need to be confirmed in larger long-term placebo-controlled studies in order to ascertain the true efficacy of these agents.
|Original language||English (US)|
|Number of pages||7|
|State||Published - Nov 1 1998|
ASJC Scopus subject areas